Mind Medicine (MindMed) Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MNMD Nasdaq 2830 www.mindmed.co

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Mind Medicine (MindMed) Inc.

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care. - Feb 12th, 2025 6:25 pm
MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Feb 4th, 2025 12:00 pm
Mind Medicine doses first patient in Panorama study - Jan 31st, 2025 12:20 pm
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder - Jan 30th, 2025 12:00 pm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Jan 20th, 2025 3:48 pm
MindMed to Be Added to the Nasdaq Biotechnology Index - Dec 19th, 2024 12:00 pm
MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) - Dec 16th, 2024 12:00 pm
MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress - Dec 11th, 2024 12:00 pm
MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD) - Dec 5th, 2024 12:00 pm
MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy - Dec 3rd, 2024 12:00 pm
MindMed Announces New Employee Inducement Grants - Dec 2nd, 2024 12:00 pm
MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer - Nov 18th, 2024 12:00 pm
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions - Nov 14th, 2024 12:26 pm
MindMed to Participate in Upcoming Investor Conferences - Nov 13th, 2024 12:00 pm
MindMed Reports Third Quarter 2024 Financial Results and Business Updates - Nov 7th, 2024 9:01 pm
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update - Oct 24th, 2024 11:00 am
Mind Medicine assumed with an Outperform at Leerink - Oct 12th, 2024 10:05 pm
MindMed to Participate in September Investor Conferences - Sep 4th, 2024 11:00 am
MindMed Reports Second Quarter 2024 Financial Results and Business Updates - Aug 13th, 2024 11:00 am
Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering - Aug 9th, 2024 12:44 pm